DOCSLIB.ORG

National Institute of Justice

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
National Institute of Justice If you have issues viewing or accessing this file contact us at NCJRS.gov. U.S. Department of Justice bffice of Justice Programs National Institute ofJustice National Institute of Justice . I 5 5 U e 5 a n..d P r a. c tic e 5 . 152768 U.S. Department of Justice co National Institute of Justice This document has been reproduced exactly as received from the person or organization originating it. Points of view or opinions stated in CD this document are those of the authors and do not necessarily represent the official position or policies of the National Institute of Justice. I'­ Permission to reproduce this _ g ;J material has been granted by Pub1:LC D::>rnain/OJP /NIJ N u.s. Depa.rtIrent of Justice LO I to the National Criminal Justice Reference Service (NCJRS). Further reproduction outside of the NCJRS system requires permission I of the~owner. I \ I ! . , !: .. ,•.•.. " •.•.•:.-:- ...... , H e a ,I t han .d J. U 5 t i ~ e. '. I J __~ ___ ~""'_-; ____';-"".r About the National Institute of Justice The National Institute of Justice (NU), a component of the • The research and development program that resulted in Office ofJustice Programs, is the research and development the creation of police body armor that has meant the agency of the U.S. Department of Justice. NIJ was estab­ difference between life and death to hundreds of police lished to prevent and reduce crime and to improve the officers. criminal justice system. Specific mandates established by Congress in the Omnibus Crime Control and S afe Streets Act • Pioneering scientific advances such as the research and of 1968, as amended, and the Anti-Drug Abuse Act of 1988 development of DNA analysis to positively identify direct the National Institute of Justice to: suspects and eliminate the innocent from suspicion. • Sponsor special projects, and research and develop­ The evaluation of innovative justice programs to deter­ ment programs that will improve and strengthen the mine what works, including drug enforcement. commu­ criminal justice system and reduce or prevent crime. nity policing, community anti-drug initiatives, prosecu­ tion of complex drug cases, drug testing throughout the • Conduct national demonstration projects that employ criminal justice system, and user accountability pro- innovative or promising approaches for improving crimi­ grams. nal justice. • Creation of a corrections information-sharing system • Develop new technologies to fight crime and improve that enables State and local officials to exchange more criminal justice. efficient and cost-effective concepts and techniques for planning, financing, and constructing new prisons and • Evaluate the effectiveness ofcriminal justice programs jails. and identify programs that promise to be successful if continued or repeated. • Operation of the world's largest criminal justice infor­ mation clearinghouse, a resource used by State and local • Recommend actions that can be taken by Federal, State, officials across the Nation and by criminal justice agen­ and local governments as well as by private organiza­ cies in foreign countries. tions to improve criminal justice. Carry out research on criminal behavior. The Institute Director, who is appointed by the President and confirmed by the Senate, establishes the Institute's objec­ • Develop new methods of crime prevention and reduc­ tives, guided by the priorities of the Office of Justice Pro­ tion of crime and delinquency. grams, the Department of Justice, and the needs of the criminal justice field. The Institute actively solicits the views The National Institute of Justice has a long history of of criminaljustice professionals to identify their most critical accomplishments, including the following: problems. Dedicated to the priorities of Federal, State, and local criminal justice agencies, research and development at Basic research on career criminals that led to develop­ the National Institute of Justice continues to search for ment of special police and prosecutor units to deal with answers to what works and why in the Nation's war on drugs repeat offenders. and crime. • Research that confirmed the link between drugs and crime. U.S. Department of Justice Office of Justice Programs National Institute of Justice NCJRS JUN 't 1995 ACQUISITION!; Managing Prison Health Care and Costs by Douglas C. McDonald May 1995 Issues and Practices in Criminal Justice is a publication series of the National Institute ofJustice. Each report presents the program options and management issues in a topic area, based on a review of research and evaluation findings, operational experience, and expert opinion on the subject. The intent is to provide information to make informed choices in planning, implementing, and improving programs and practice in criminal justice. National Institute of Justice Jeremy Travis Director Cheryl Crawford Program Monitor Advisory Panel B. Jaye Anno, Ph.D. Chase Riveland Consultant in Correctional Care Secretary 54 Balsam Road Department of Corrections Santa Fe, NM 87505 State of Washington P.O. Box 41101 John Byus Olympia, WA 98404-1101 Administrator of Medical and Dental Services Arkansas Department of Corrections Ronald Waldron, Ph.D. P.O. Box 8707 Senior Deputy Assistant Director Pine Bluff, AR 71611 Health Services Division Federal Bureau of Prisons Kenneth P. Moritsugu, M.D., M.P.H. 320 First Street NW Assistant Surgeon General and Medical Director Washington, DC 20534 Federal Bureau of Prisons 320 First Street NW Robert Watson Washington, DC 20534 Commissioner Department of Correction James E. Riley State of Delaware Executive Director 80 Monrovia Ave. Correctional Managed Health Care Smyrna, DE 19977-1597 State of Texas P.O. Box 99 Huntsville, TX 77343-0099 Prepared for the Nationallnstitute ofJustice, U.S. Department ofJustice by Abt Associates Inc., under contract #OJP-94-C-007. Points of view or opinions stated in this document are those of the authors and do not necessarily represent the official position or policies of the U.S. Department of Justice. The National Institute of Justice is a component of the Office of Justice Programs, which also includes the Bureau of Justice Assistance, the Bureau of Justice Statistics, the Office of Juvenile Justice and Delinquency Prevention, and the Office for Victims of Crime. NCJ 152768 Table of Contents Foreword .......................................................................................................................................................... iii Acknowledgements ............................................................................................................................................. v Executive Summary .......................................................................................................................................... , vii Chapter 1: The Rising Cost of Care ..................................................................... :.............................................. 1 Pressures on Health Care Spending in the Coming Years .......................................................................... 2 The Need for Effective Management ......................................................................................................... 4 Chapter 2: Emerging Strategies To Manage Costs and Care .............................................................................. 7 Features of "Unmanaged" Health Care That Affect Costs ......................................................................... 7 The Development of Managed Care To Contain Costs and Change Patterns of Practice ........................ 10 New Forms of Organization ..................................................................................................................... 12 Is Managed Care Less Costly and More Cost-Effective? ......................................................................... 14 Will Conditions in American Prisons Support Cost-Effective Managed Health Care? ........................... 16 Chapter 3: Containing Costs of Goods and Services ........................................................................................ 21 Negotiating Better Prices for Pharmaceuticals ............................................................. :........................... 21 Reduced Prices for Purchased Hospital Services .............................. :...................................................... 22 Getting Reduced Prices From Physicians ................................................................................................. 29 "Making" Rather Than Buying Hospital Services .................................................................................... 29 Sharing Services .......................................................... :............................................................................ 34. Hiring Physicians on Staff or on Contract ................................................................................................ 36 Controlling Costs by Reviewing Bills ...................................................................................................... 37 Summary ................................................................................................................................................... 37 Chapter 4: Controlling the Utilization of Health Care Services .............................................. :......................... 41 Regulatory Policies: Limiting Health Care Services ..............................................................................
Load more

Recommended publications
  • Thoracic Actinomycosis P
    Thorax (1973), 28, 73. Thoracic actinomycosis P. R. SLADE, B. V. SLESSER, and J. SOUTHGATE Groby Road Hospital, Leicester Six cases of pulmonary infection with Actinomyces Israeli and one case of infection with Nocardia asteroides are described. The incidence of thoracic actinomycosis has declined recently and the classical presentation with chronic discharging sinuses is now uncommon. The cases described illustrate some of the forms which the disease may take. Actinomycotic infection has been noted, not infrequently, to co-exist with bronchial carcinoma and a case illustrating this association is described. Sputum cytology as practised for the diagnosis of bronchial carcinoma has helped to identify the fungi in the sputum. Treatment is discussed, particularly the possible use of oral antibiotics rather than penicillin by injection. Actinomycosis is not common in this country. showed only submucosal fibrosis. Cytological exam- The Table shows the number of cases reported to ination of the sputum showed the presence of fungus Health Laboratory Service from public (Figs 2 and 3) and cultures gave a growth of the Public Actinomyces Israeli. The patient was hypersensitive to health and hospital laboratories in the United penicillin and was treated with oral tetracycline, 2 g Kingdom and Republic of Ireland in recent years. daily for six months. There was marked reduction It is usually considered that the chest may be in the shadowing on the chest film after only six involved in about 15% of cases (Cecil and Loeb, weeks of treatment (Fig. 4) and subsequently com- 1963). But, of the 36 cases reported in 1970, the plete disappearance. The patient has remained well chest was involved in only one case.
    [Show full text]
  • Quantitative Sputum Culture As a Means of Excluding False Positive Reports in the Routine Microbiology Laboratory
    J Clin Pathol: first published as 10.1136/jcp.25.8.697 on 1 August 1972. Downloaded from J. clin. Path., 1972, 25, 697-700 Quantitative sputum culture as a means of excluding false positive reports in the routine microbiology laboratory M. J. B. WILSON AND D. E. MARTIN From the Department of Microbiology, Royal Perth Hospital, Perth, Western Australia SYNOPSIS A relatively simple technique for sputum homogenization and dilution is described. Results show that this technique is reliable for isolation and quantitative culture of organisms from cases of chest infection. The technique has resulted in significant reduction in false positive reports, particularly when a system of interpretative reporting is utilized based on 107 organisms per millilitre of sputum being accepted as evidence of significant infection. The bacteriology of human excretions, particularly A critical analysis of sputum culture results from sputum and urine, has given rise to considerable our laboratory showed that there was frequently a difficulties in interpretation. Kass (1957) contributed good growth of a potential pathogen when clinical much to the better understanding of the significance evidence for infection was equivocal and there was a of non-catheter urine culture when he introduced the tendency for the laboratory to make an excessive copyright. concept of colony counts, in an effort to distinguish number of false positive reports using standard between infected urine and urine from normal culture methods. These false positive reports are persons contaminated by urethral flora. Lower misleading and make it difficult to manage cases respiratory tract infections may likewise show a effectively, and they may lead to unwarranted and heavy growth of commensal organisms, because of undesirable antibiotic usage.
    [Show full text]
  • Specimen Collection: Sputum (Home Health Care) - CE
    Specimen Collection: Sputum (Home Health Care) - CE ALERT Don appropriate personal protective equipment (PPE) based on the patient’s signs and symptoms and indications for isolation precautions. Bronchospasm or laryngospasm, as a result of suctioning, can be severe and prolonged, and, in some cases, can be life-threatening without intervention. OVERVIEW Sputum is produced by cells that line the respiratory tract. Although production is minimal in the healthy patient, disease processes can increase the amount or change the character of sputum. Examination of sputum aids in the diagnosis and treatment of many conditions such as bronchitis, bronchiectasis, tuberculosis (TB), pneumonia, and pulmonary abscess, or lung cancer.3 In many cases, suctioning is indicated to collect sputum from a patient who cannot spontaneously produce a sample for laboratory analysis. Suctioning may provoke violent coughing, induce vomiting, and result in aspiration of stomach contents. Suctioning may also induce constriction of the pharyngeal, laryngeal, and bronchial muscles. In addition, suctioning may cause hypoxemia or vagal overload, causing cardiopulmonary compromise and an increase in intracranial pressure. Sputum for cytology, culture and sensitivity, and acid-fast bacilli (AFB) are three major types of sputum specimens.3 Cytologic or cellular examination of sputum may identify aberrant cells or cancer. Sputum collected for culture and sensitivity testing can be used to identify specific microorganisms and determine which antibiotics are the most sensitive. The AFB smear is used to support a diagnosis of TB. A definitive diagnosis of TB also requires a sputum culture and sensitivity.3 Regardless of the test ordered, a sputum specimen should be collected first thing in the morning due to a greater accumulation of bronchial secretions overnight.
    [Show full text]
  • Violent Offender Incarceration and Truth-In-Sentencing Incentive Formula Grant Program
    U.S. Department of Justice Office of Justice Programs Bureau of Justice Assistance REPORT TO CONGRESS Violent Offender Incarceration and Truth-In-Sentencing Incentive Formula Grant Program February 2012 Submitted by: Table of Contents Introduction 1 Funding History 1 Eligibility Requirements 2 Appendixes A. Fiscal Years 1996–2001 VOI/TIS Funding 4 B. VOI/TIS Program Activities by State 6 Introduction Title II, Subtitle A of the Violent Crime Control and Law Enforcement Act of 1994 (“Crime Act”) (Pub. L. 103-322), established the Violent Offender Incarceration and Truth-in-Sentencing (VOI/TIS) Incentive Grant Program. The program assisted states in their efforts to remove violent offenders from the community and encouraged states to implement TIS laws. Originally administered by the Office of Justice Programs’ (OJP) Corrections Program Office (CPO), the program was transferred to OJP’s Bureau of Justice Assistance (BJA) in November 2002 after an OJP-wide reorganization merged CPO with BJA. The VOI/TIS Program provided formula grants to states to build or expand correctional facilities and jails to increase secure confinement space for violent offenders. From fiscal years (FYs) 1996 to 2001, half of the funds were made available for VOI grants and half were available as incentive awards to states that implemented TIS laws. VOI/TIS grant funds allowed states to build or expand correctional facilities to increase bed capacity for the confinement of persons convicted of Part 1 violent crimes or adjudicated delinquents who had committed equivalent acts. Funds were also used to build or expand temporary or permanent correctional facilities, including facilities on military bases, prison barges, and boot camps; to confine convicted nonviolent offenders and criminal aliens; or to free suitable existing prison space for the confinement of persons convicted of Part 1 violent crimes.
    [Show full text]
  • 11736 Lab Req Red-Blue
    3550 W. Peterson Ave., Ste. 100 ACCOUNT: Chicago, Illinois 60659 Tel: 773-478-6333 Fax: 773-478-6335 LABORATORY REQUISITION PATIENT NAME - LAST FIRST MIDDLE INITIAL PATIENT IDENTIFICATION SOCIAL SECURITY NO. DATE OF BIRTH SEX N O I NAME OF INSURED SS# OF INSURED RELATIONSHIP TO PATIENT T A M R O PATIENT/INSURED ADDRESS PHONE NUMBER MEDICARE NO. (INCLUDING ALPHA CHARACTERS) F Please attach an ABN form. N I G N CITY STATE ZIP CODE I L L I MEDICAID NO. B BILL I PHYSICIAN I PATIENT I MEDICARE I MEDICAID I INSURANCE (attach copy of both sides of card) TO ACCOUNT DIAGNOSIS (CD-9 CODE(S)) (REQUIRED FOR 3RD PARTY BILLING) PLEASE WRITE PATIENT’S NAME ON ALL SPECIMENS DATE COLLECTED COLLECTED BY AM DR. NAME / NPI # DR. OR RN SIGNATURE PM 001 GENERAL HEALTH PROFILE ( Male ) - CBC, CMP, LIPID, TSH, FT4, TT3, FERRITIN, PSA, H-PYLORI, MAG, ESR, UA, IRON/TIBC SST, L, U 002 GENERAL HEALTH PROFILE ( Female ) - CBC, CMP, LIPID, TSH, FT4, TT3, FERRITIN, H-PYLORI, MAG, ESR, UA, IRON/TIBC SST, L, U 003 AMENOR/MENSTR. DISORDER - CMP, LIPID, CBC, TSH, FT4, TT3, ESR, IRON/TIBC, FERRITIN, MAG, UA, HCG, FSH, LH, PROLACTIN, RET COUNT SST, L, U 004 ANEMIA - CMP, LIPID, IRON/TIBC, CBC, FERRITIN, TSH, FT4, TT3, H-PYLORI, UA, G6PD, RET COUNT SST, L, U 005 ARTHRITIS - CMP, LIPID, CBC, URIC ACID, ESR, ASO, CRP, ANA, RH, SLE SST, L, U 006 DIABETES - CMP, LIPID, CBC, HBA1C, CORTISOL, TSH, FT4, TT3, UA, RET COUNT SST, L, U 007 HEPATITIS - HAAB IGM, HBCAB IGM, HBSAB, HBSAG, HCAB, SGOT, SGPT SST 008 HYPERTENSION/CARDIAC - CMP, LIPID, CBC, TSH, FT4, TT3, IRON/TIBC, CPK, CORTISOL,
    [Show full text]
  • Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery
    SURGICAL INFECTIONS Volume 14, Number 1, 2013 Surgical Infection Mary Ann Liebert, Inc. DOI: 10.1089/sur.2013.9999 Society Guidelines Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery Dale W. Bratzler,1 E. Patchen Dellinger,2 Keith M. Olsen,3 Trish M. Perl,4 Paul G. Auwaerter,5 Maureen K. Bolon,6 Douglas N. Fish,7 Lena M. Napolitano,8 Robert G. Sawyer,9 Douglas Slain,10 James P. Steinberg,11 and Robert A. Weinstein12 hese guidelines were developed jointly by the Ameri- the project. Panel members and contractors were required to Tcan Society of Health-System Pharmacists (ASHP), the disclose any possible conflicts of interest before their ap- Infectious Diseases Society of America (IDSA), the Surgical pointment and throughout the guideline development pro- Infection Society (SIS), and the Society for Healthcare Epide- cess. Drafted documents for each surgical procedural section miology of America (SHEA). This work represents an update were reviewed by the expert panel and, once revised, were to the previously published ASHP Therapeutic Guidelines on available for public comment on the ASHP website. After Antimicrobial Prophylaxis in Surgery [1], as well as guide- additional revisions were made to address reviewer com- lines from IDSA and SIS [2,3]. The guidelines are intended to ments, the final document was approved by the expert panel provide practitioners with a standardized approach to the and the boards of directors of the above-named organizations. rational, safe, and effective use of antimicrobial agents for the prevention of surgical site infections (SSIs) based on currently Strength of evidence and grading of recommendations available clinical evidence and emerging issues.
    [Show full text]
  • State of Nevada Department of Administration Division of Internal Audits
    State of Nevada Department of Administration Division of Internal Audits Audit Report Department of Corrections Report No. 13-03 December 2012 INTRODUCTION At the direction of the Executive Branch Audit Committee, we conducted an audit of the Nevada Department of Corrections (Department). Our audit addressed the following four questions: ./ What is the Department's role? ./ What services must the Department provide? ./ Is the State the proper level of government to provide these services? ./ If State government is the appropriate level of government, is the Department carrying out its duties efficiently and effectively? Our audit focused on whether the Department can enhance oversight of doctors, expedite hiring processes and enhance the prison industries program. Department's Role and Public Purpose The Nevada State Prison was established in 1864; the name was changed to Department of Corrections in 2001. The Department is overseen by the Board of Prison Commissioners (Board) which consists of the Governor, Secretary of State, and the Attorney General. The Governor serves as the President of the Board, and the Secretary of State serves as the Secretary. The Department has seven correctional facilities, ten conservation camps, one restitution center and one transitional housing facility. In addition, the Department administers the Prison Medical Division and Silver State Industries (Prison Industries). The Director of the Department is appointed by the Governor and reports to the Board. The Director is responsible for the administration and supervision of all institutions and facilities. The Director is also responsible for employing individuals to facilitate the supervision, custody, treatment, care, security and discipline of all offenders under the jurisdiction of the Department.
    [Show full text]
  • Antimicrobial Treatment Guidelines for Common Infections
    Antimicrobial Treatment Guidelines for Common Infections March 2019 Published by: The NB Provincial Health Authorities Anti-infective Stewardship Committee under the direction of the Drugs and Therapeutics Committee Introduction: These clinical guidelines have been developed or endorsed by the NB Provincial Health Authorities Anti-infective Stewardship Committee and its Working Group, a sub- committee of the New Brunswick Drugs and Therapeutics Committee. Local antibiotic resistance patterns and input from local infectious disease specialists, medical microbiologists, pharmacists and other physician specialists were considered in their development. These guidelines provide general recommendations for appropriate antibiotic use in specific infectious diseases and are not a substitute for clinical judgment. Website Links For Horizon Physicians and Staff: http://skyline/patientcare/antimicrobial For Vitalité Physicians and Staff: http://boulevard/FR/patientcare/antimicrobial To contact us: [email protected] When prescribing antimicrobials: Carefully consider if an antimicrobial is truly warranted in the given clinical situation Consult local antibiograms when selecting empiric therapy Include a documented indication, appropriate dose, route and the planned duration of therapy in all antimicrobial drug orders Obtain microbiological cultures before the administration of antibiotics (when possible) Reassess therapy after 24-72 hours to determine if antibiotic therapy is still warranted or effective for the given organism
    [Show full text]
  • Diagnostic Value of Bronchoalveolar Lavage in the Subset of Patients With
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Qatar University Institutional Repository International Journal of Infectious Diseases 82 (2019) 96–101 Contents lists available at ScienceDirect International Journal of Infectious Diseases journal homepage: www.elsevier.com/locate/ijid Diagnostic value of bronchoalveolar lavage in the subset of patients with negative sputum/smear and mycobacterial culture and a suspicion of pulmonary tuberculosis a b, c c Mushtaq Ahmad , Wanis H. Ibrahim *, Sabir Al Sarafandi , Khezar S. Shahzada , c c d e c Shakeel Ahmed , Irfan Ul Haq , Tasleem Raza , Mansoor Ali Hameed , Merlin Thomas , c c Hisham Ab Ib Swehli , Hisham A. Sattar a Department of Medicine, Hamad General Hospital, Weill-Cornell Medical College, Doha, Qatar b Hamad General Hospital, Qatar University and Weill-Cornell Medical College, Doha, Qatar c Department of Medicine, Hamad General Hospital, Doha, Qatar d Hamad General Hospital, Weill-Cornell Medical College, Doha, Qatar e Hamad General Hospital, Doha, Qatar A R T I C L E I N F O A B S T R A C T Article history: Background: The diagnostic value of bronchoalveolar lavage in patients with negative sputum/smear for Received 31 January 2019 tuberculous bacilli has been well studied. However, its value in the subset of patients with both negative Received in revised form 10 March 2019 sputum/smear and culture is seldom reported. Accepted 14 March 2019 Methods: A retrospective study of patients referred for diagnostic bronchoscopy for the suspicion of Corresponding Editor: Eskild Petersen, Aar- pulmonary tuberculosis during the period from April 1st, 2015 to March 30th, 2016, and who had hus, Denmark negative sputum/smear and culture for tuberculous bacilli.
    [Show full text]
  • Sentencing Reform and Alternatives to Incarceration
    Background Paper 87-6 SENTENCING REFORM AND ALTERNATIVES TO INCARCERATION TABLE OF CONTENTS I . I ntrod u ct i on. 1 II. Recommendations From Legislative Studies........ 2 A. Nevada Prison System Study.................. 3 B. Prison Master Plan Study.................... 5 C. Study Of Parole Function.................... 6 1. Senten c i n g Gu i de 1 in es . 6 2. Paro 1 e Gu i de 1 i ne s . 7 3. Revisions in Good Time Credits.......... 7 4. Expansion of Honor Camp Program......... 8 5. Expansion of Parole Board............... 8 D. Felony Sentencing Commission's Report....... 8 1. Pro bat i on Rev oc at i on s . 9 2. Con s ec uti ve Sen ten ces . 9 3. Mandatory Sentences..................... 9 4. Pre -Sen ten ce Report s . 9 5. Monetary Distinction Between Misdemeanor and Felony in Property Crimes........... 10 6. Further Study........................... 10 I I 1. Alternatives For Alcohol And Drug Offenders ..... 10 A. Alternatives To Incarceration For Convicted DU I Offe nder s . 10 B. Treatment Programs For Drunk Drivers........ 10 1. Arizona's Separate Facilities Approach.. 11 2. Nevada's Approach to DUI Convictions.... 12 ~ I V. Alter nat i ve s For Se x Off en der s . 13 A. Se x Offen der St at i s tic s . 13 B. Punishment Of Sex Offenders In Nevada....... 14 C. Methods Of Treatment For Sex Offenders...... 15 D. The Sex Offender Unit Correctional Treatment Program At The Oregon State Hospital........ 15 V. IIBoot Campll Incarceration....................... 17 A. State Programs.............................. 17 B. Program Results............................. 18 VI.
    [Show full text]
  • Judiciary Exhibit: N Page 1 of 110 Date: 03/31/2021 Submitted By
    LA 14-25 State of Nevada Performance Audit Fiscal Costs of the Death Penalty 2014 Legislative Auditor Carson City, Nevada Audit Fiscal Costs of the Death Penalty Highlights Summary Adjudicating death penalty cases takes more time and resources compared to murder cases where Highlights of performance audit report on the the death penalty sentence is not pursued as an option. These cases are more costly because Fiscal Costs of the Death Penalty issued on there are procedural safeguards in place to ensure the sentence is just and free from error. Based December 2. 2014. Legislative Auditor report on our sample of 28 cases and average costs we were able to accumulate, we estimate the death # LA14-25. penalty, from arrest through the end of incarceration, costs about $532,000 more than other murder cases where the death penalty is not sought, (page 10) Background________________ The death penalty in the United States is applied Cost Differential of the Death Penalty almost exclusively for the crime of murder. As $1,400,000 of August 2014. 32 states have laws allowing $1,307,000 $1,200,000 $1,202,000 death as a sentencing option although governors $1,032,000 in Washington and Oregon have issued $1,000,000 moratoriums on executions. $800,000 $775,000 Two U.S. Supreme Court cases significantly $600,000 impacted states’ laws regarding the death $400,000 penalty. Furman v. Georgia in 1972 invalidated death penalty laws because the legal system, as $200,000 it was then structured, allowed for the death $0 penalty to be imposed in an arbitrary manner.
    [Show full text]
  • Video Thoracoscopic Surgery Used to Manage Tuberculosis in Thoracic Surgery
    Surg Endosc (2005) 19: 1341–1344 DOI: 10.1007/s00464-004-2130-6 View metadata,Ó Springer citation Science+Business and similar papers Media, at core.ac.uk Inc. 2005 brought to you by CORE provided by RERO DOC Digital Library Video thoracoscopic surgery used to manage tuberculosis in thoracic surgery M. Beshay,1 P. Dorn,1 J. R. Kuester,1 G. L. Carboni,1 M. Gugger,2 R. A. Schmid1 1 Division of General Thoracic Surgery, University Hospital Berne, Berne, 3010, Switzerland 2 Institute of Pathology, University Hospital Berne, Berne, 3010, Switzerland Received: 7 June 2004/Accepted: 11 February 2005/Online publication: 23 June 2005 Abstract mised patients, especially human immuno deficiency Background: The aim of this study was to evaluate the virus (HIV) seropositive patients, or to increasing indications and results of video-assisted thoracic surgery immigration [2, 10, 11, 13]. Thus, it appears that the (VATS) for the management of tuberculosis in 10 pa- clinical and radiologic presentation of tuberculosis has tients with unusual clinical and radiologic presentation changed to more unusual manifestations. With the for the disease. dramatic improvement of video-assisted thoracic sur- Methods: From March 2000 to March 2002, 96 diag- gery (VATS), this approach for the diagnosis of different nostic VATS operations for unclear thoracic lesions thoracic lesions is recommended as standard, and is were performed at the authorsÕ institution. Their final becoming popular for the diagnosis of TB [15]. diagnosis for 10 (10.4%) of these patients was tubercu- Hans Christian Jacobaeus [4], a Swedish internist, is losis. The suspected preoperative diagnoses were pan- generally known as the first to undertake an endoscopic coast tumour (n = 1), pericardial effusion (n = 1), exploration of the thorax in 1910 to break pleural pleural mesothelioma (n = 1), pleural empyema adhesions with the patient under local anesthesia to (n = 2), mediastinal lymphoma (n = l), and lung can- facilitate collapse therapy for pulmonary tuberculosis.
    [Show full text]